Recurrent, Nonrecurrent, and De Novo Membranous Nephropathy After Kidney Transplantation: A Systematic Review and Meta-Analysis

20260 citationsJournal Articlegold Open Access

Authors

Thanyarat Phumthian · Thai Red Cross Society

Veerapat Wattanasatja · Thai Red Cross Society

Aschariya Wipattanakitcharoen · Thai Red Cross Society

Thunyatorn Wuttiputhanun · Thai Red Cross Society

Asada Leelahavanichkul · Chulalongkorn University

Natavudh Townamchai · Thai Red Cross Society

Yingyos Avihingsanon ·

Abstract

MN recurs in approximately one-third of recipients. Protocol biopsy should be utilized in recipients with history of native MN. Rituximab emerges as the preferred first-line treatment for recurrent MN.

Topics & Keywords

Renal Diseases and Glomerulopathies Renal and Vascular Pathologies Renal Transplantation Outcomes and Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Kidney Medicine

Volume 8, Issue 4, pp. 101284-101284

DOI: 10.1016/j.xkme.2026.101284

Field-Weighted Citation Impact: 0.00